Updated insights into the mechanism of action and clinical profile of the immunoadjuvant QS-21: A review()

BACKGROUND: Vaccine adjuvants are compounds that significantly enhance/prolong the immune response to a co-administered antigen. The limitations of the use of aluminium salts that are unable to elicite cell responses against intracellular pathogens such as those causing malaria, tuberculosis, or AID...

Descripción completa

Detalles Bibliográficos
Autor principal: Lacaille-Dubois, Marie-Aleth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier GmbH. 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127804/
https://www.ncbi.nlm.nih.gov/pubmed/31182297
http://dx.doi.org/10.1016/j.phymed.2019.152905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127804/
https://www.ncbi.nlm.nih.gov/pubmed/31182297
http://dx.doi.org/10.1016/j.phymed.2019.152905

Ejemplares similares